Danaher (DHR) Teams Up to Advance Precision Medicine Diagnostics

Danaher Corporation (NYSE:DHR) is one of the 13 Best Large Cap Stocks to Buy Right Now. On May 29, Danaher Corporation (NYSE:DHR) announced a new partnership with AstraZeneca to scale precision medicine.

This partnership aims to create and commercialize novel diagnostic tools and tests, including the new generation of AI-powered diagnostics. These tools and tests would be designed to help clinicians better determine which patients would benefit most from precision medicine treatments.

Danaher (DHR) Teams Up to Advance Precision Medicine Diagnostics

A healthcare professional in a lab coat holding a microscope and looking at a slide under the lens.

Danaher Corporation (NYSE:DHR) pointed out that this collaboration will use the recently opened Danaher Centers for Enabling Precision Medicine to help make the development process smoother and more efficient.

The first product planned for development will use technologies from Leica Biosystems, one of Danaher Corporation’s (NYSE:DHR) subsidiaries.

The partnership will initially focus on digital and computational pathology products and AI-assisted algorithms. These products will help clinicians diagnose patients more accurately and find out who is most likely to benefit from targeted therapies.

Danaher Corporation (NYSE:DHR) is a leading global life sciences and diagnostics innovation company. With a focus on science and technology, the company helps discover, develop, and deliver life-changing therapies.

While we acknowledge the potential of DHR as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than DHR and that has a 100x upside potential, check out our report about the cheapest AI stock.

READ NEXT: 10 Best American Semiconductor Stocks to Buy Now and 11 Best Fintech Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.